REGEN BIOPHARMA, INC. Amortization of Debt Discount (Premium)
REGEN BIOPHARMA, INC. (RGBP) reported Amortization of Debt Discount (Premium) of $8.75 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-17
- REGEN BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2026-06-30 was $8.75K, a 30.75% decline year-over-year.
- REGEN BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2026-03-31 was $8.66K, a 31.51% decline year-over-year.
- REGEN BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $8.85K, a 29.98% decline year-over-year.
- REGEN BIOPHARMA, INC. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $14.23K, a 10.79% decline year-over-year.
- REGEN BIOPHARMA, INC. amortization of debt discount (premium) for fiscal 2025 was $52.15K, a 79.83% increase from fiscal 2024.
- REGEN BIOPHARMA, INC. amortization of debt discount (premium) for fiscal 2024 was $29.00K, a 3256.25% increase from fiscal 2023.
- REGEN BIOPHARMA, INC. amortization of debt discount (premium) for fiscal 2023 was $864.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.75K 10-Q · filed 2026-08-17 | $17.41K derived: sum of 2 quarters · filed 2026-08-17 | $26.26K 10-Q · filed 2026-08-17 | $40.49K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $8.66K 10-Q · filed 2026-05-14 | $17.51K 10-Q · filed 2026-05-14 | $31.74K derived: sum of 3 quarters · filed 2026-05-14 | $44.38K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $8.85K 10-Q · filed 2026-02-13 | $23.08K derived: sum of 2 quarters · filed 2026-02-13 | $35.72K derived: sum of 3 quarters · filed 2026-08-17 | $48.36K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-09-30 | $14.23K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-30 | $26.87K derived: sum of 2 quarters · filed 2026-08-17 | $39.51K derived: sum of 3 quarters · filed 2026-08-17 | $52.15K 10-K · filed 2025-12-30 |
| 2025-06-30 | $12.64K 10-Q · filed 2026-08-17 | $25.28K derived: sum of 2 quarters · filed 2026-08-17 | $37.92K 10-Q · filed 2026-08-17 | $53.87K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $12.64K 10-Q · filed 2026-05-14 | $25.28K 10-Q · filed 2026-05-14 | $41.23K derived: sum of 3 quarters · filed 2026-05-14 | $45.57K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $12.64K 10-Q · filed 2026-02-13 | $28.59K derived: sum of 2 quarters · filed 2026-02-13 | $32.93K derived: sum of 3 quarters · filed 2026-02-13 | $37.27K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | $15.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-30 | $20.29K derived: sum of 2 quarters · filed 2025-12-30 | $24.63K derived: sum of 3 quarters · filed 2025-12-30 | $29.00K 10-K · filed 2025-12-30 |
| 2024-06-30 | $4.34K 10-Q · filed 2025-08-11 | $8.68K derived: sum of 2 quarters · filed 2025-08-11 | $13.04K 10-Q · filed 2025-08-11 | |
| 2024-03-31 | $4.34K 10-Q · filed 2025-05-28 | $8.71K 10-Q · filed 2025-05-28 | ||
| 2023-12-31 | $4.37K 10-Q · filed 2025-05-16 | |||
| 2023-09-30 | $864.00 10-K · filed 2025-05-13 |